Published in Ann N Y Acad Sci on June 01, 2002
Materials science and tissue engineering: repairing the heart. Mayo Clin Proc (2013) 0.87
The "artificial artery" as in vitro perfusion model. PLoS One (2013) 0.82
Bioactive polymer scaffold for fabrication of vascularized engineering tissue. J Artif Organs (2012) 0.80
Does mechanical stimulation have any role in urinary bladder tissue engineering? World J Urol (2008) 0.80
Biodegradable Materials for Bone Repair and Tissue Engineering Applications. Materials (Basel) (2015) 0.79
Microvascular guidance: a challenge to support the development of vascularised tissue engineering construct. ScientificWorldJournal (2012) 0.78
Nanomaterials can dynamically steer cell responses to biological ligands. Small (2010) 0.75
Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol (2007) 9.67
Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. Lancet (2011) 3.95
Engineering complex tissues. Tissue Eng (2006) 2.53
Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells (2004) 2.32
Carbon nanotube applications for tissue engineering. Biomaterials (2006) 2.25
Anterior urethral valves and diverticula in children: a result of ruptured Cowper's duct cyst? BJU Int (2004) 2.19
The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology (2011) 2.09
Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat. J Mol Cell Cardiol (2006) 1.99
Generation of histocompatible tissues using nuclear transplantation. Nat Biotechnol (2002) 1.97
Antiangiogenic properties of gold nanoparticles. Clin Cancer Res (2005) 1.78
Controlled fabrication of a biological vascular substitute. Biomaterials (2005) 1.76
Cell-seeded tubularized scaffolds for reconstruction of long urethral defects: a preclinical study. Eur Urol (2012) 1.69
Tissue engineering, stem cells, and cloning: opportunities for regenerative medicine. J Am Soc Nephrol (2004) 1.68
Implantation of autologous urine derived stem cells expressing vascular endothelial growth factor for potential use in genitourinary reconstruction. J Urol (2011) 1.56
Decellularization methods of porcine kidneys for whole organ engineering using a high-throughput system. Biomaterials (2012) 1.55
Urine derived cells are a potential source for urological tissue reconstruction. J Urol (2008) 1.54
Bioengineered vascular access maintains structural integrity in response to arteriovenous flow and repeated needle puncture. J Vasc Surg (2012) 1.52
The influence of electrospun aligned poly(epsilon-caprolactone)/collagen nanofiber meshes on the formation of self-aligned skeletal muscle myotubes. Biomaterials (2008) 1.47
Whole organ decellularization - a tool for bioscaffold fabrication and organ bioengineering. Conf Proc IEEE Eng Med Biol Soc (2009) 1.47
The in vivo stability of electrospun polycaprolactone-collagen scaffolds in vascular reconstruction. Biomaterials (2008) 1.46
Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells (2008) 1.46
Multipotential differentiation of human urine-derived stem cells: potential for therapeutic applications in urology. Stem Cells (2013) 1.46
Randomized comparative study between buccal mucosal and acellular bladder matrix grafts in complex anterior urethral strictures. J Urol (2008) 1.45
Engineered multilayer ovarian tissue that secretes sex steroids and peptide hormones in response to gonadotropins. Biomaterials (2012) 1.45
Production and implantation of renal extracellular matrix scaffolds from porcine kidneys as a platform for renal bioengineering investigations. Ann Surg (2012) 1.45
Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS One (2010) 1.44
Chondrogenic differentiation of amniotic fluid-derived stem cells. J Mol Histol (2007) 1.44
Principals of neovascularization for tissue engineering. Mol Aspects Med (2002) 1.44
Reprogramming of human somatic cells using human and animal oocytes. Cloning Stem Cells (2009) 1.40
Development of a composite vascular scaffolding system that withstands physiological vascular conditions. Biomaterials (2008) 1.35
Hybrid printing of mechanically and biologically improved constructs for cartilage tissue engineering applications. Biofabrication (2012) 1.34
Regenerative medicine as applied to solid organ transplantation: current status and future challenges. Transpl Int (2010) 1.33
Stretch and growth: the molecular and physiologic influences of tissue expansion. Plast Reconstr Surg (2002) 1.30
Human urine-derived stem cells seeded in a modified 3D porous small intestinal submucosa scaffold for urethral tissue engineering. Biomaterials (2010) 1.30
Amniotic fluid and placental stem cells. Methods Enzymol (2006) 1.30
Bilayered scaffold for engineering cellularized blood vessels. Biomaterials (2010) 1.29
Urethral stricture repair with an off-the-shelf collagen matrix. J Urol (2003) 1.26
Mesenchymal stem cells and adipogenesis in hemangioma involution. Stem Cells (2006) 1.25
Differentiation of human bone marrow mesenchymal stem cells into bladder cells: potential for urological tissue engineering. Tissue Eng Part A (2010) 1.25
Oxygen generating scaffolds for enhancing engineered tissue survival. Biomaterials (2008) 1.24
Identification and characterization of bioactive factors in bladder submucosa matrix. Biomaterials (2007) 1.24
Urethral replacement using cell seeded tubularized collagen matrices. J Urol (2002) 1.24
A rat decellularized small bowel scaffold that preserves villus-crypt architecture for intestinal regeneration. Biomaterials (2012) 1.21
Characterization of urine-derived stem cells obtained from upper urinary tract for use in cell-based urological tissue engineering. Tissue Eng Part A (2011) 1.21
Tissue-specific extracellular matrix coatings for the promotion of cell proliferation and maintenance of cell phenotype. Biomaterials (2009) 1.21
Cell cycle checkpoint function in bladder cancer. J Natl Cancer Inst (2003) 1.21
Complex heterogeneous tissue constructs containing multiple cell types prepared by inkjet printing technology. Biomaterials (2012) 1.21
Tubularized urethral replacement with unseeded matrices: what is the maximum distance for normal tissue regeneration? World J Urol (2008) 1.20
Sources of stem cells for regenerative medicine. Stem Cell Rev (2008) 1.17
Oxygen producing biomaterials for tissue regeneration. Biomaterials (2007) 1.16
Myogenic differentiation of human bone marrow mesenchymal stem cells on a 3D nano fibrous scaffold for bladder tissue engineering. Biomaterials (2009) 1.16
Regenerative medicine and organ transplantation: past, present, and future. Transplantation (2011) 1.14
Testicular volume: comparison of orchidometer and US measurements in dogs. Radiology (2002) 1.13
Human amniotic fluid stem cell preconditioning improves their regenerative potential. Stem Cells Dev (2011) 1.12
In vitro evaluation of electrospun nanofiber scaffolds for vascular graft application. J Biomed Mater Res A (2007) 1.12
Engineering functional bladder tissues. J Tissue Eng Regen Med (2012) 1.10
Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol Ther (2012) 1.10
Tissue-engineered conduit using urine-derived stem cells seeded bacterial cellulose polymer in urinary reconstruction and diversion. Biomaterials (2010) 1.08
Tissue engineering, stem cells, cloning, and parthenogenesis: new paradigms for therapy. J Exp Clin Assist Reprod (2004) 1.08
Engineering of blood vessels from acellular collagen matrices coated with human endothelial cells. Tissue Eng (2006) 1.07
Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells. Cancer Res (2003) 1.06
Propagation, expansion, and multilineage differentiation of human somatic stem cells from dermal progenitors. Stem Cells Dev (2005) 1.05
Cyclic mechanical preconditioning improves engineered muscle contraction. Tissue Eng Part A (2008) 1.04
Tissue engineering a complete vaginal replacement from a small biopsy of autologous tissue. Transplantation (2008) 1.04
A novel use of centrifugal force for cell seeding into porous scaffolds. Biomaterials (2004) 1.04
Stem cells derived from amniotic fluid: new potentials in regenerative medicine. Reprod Biomed Online (2009) 1.03
Three-dimensional culture of hepatocytes on porcine liver tissue-derived extracellular matrix. Biomaterials (2011) 1.02
Optimization of human skeletal muscle precursor cell culture and myofiber formation in vitro. Methods (2008) 1.02
Will regenerative medicine replace transplantation? Cold Spring Harb Perspect Med (2013) 1.00
Skeletal myogenic differentiation of urine-derived stem cells and angiogenesis using microbeads loaded with growth factors. Biomaterials (2012) 1.00
Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds. Biomaterials (2009) 1.00
Formation of corporal tissue architecture in vivo using human cavernosal muscle and endothelial cells seeded on collagen matrices. Tissue Eng (2003) 0.99
Self-renewal and differentiation capacity of urine-derived stem cells after urine preservation for 24 hours. PLoS One (2013) 0.99
Bioprinted amniotic fluid-derived stem cells accelerate healing of large skin wounds. Stem Cells Transl Med (2012) 0.98
Cell and organ bioengineering technology as applied to gastrointestinal diseases. Gut (2012) 0.98
Optimization of a natural collagen scaffold to aid cell-matrix penetration for urologic tissue engineering. Biomaterials (2009) 0.98
In vitro generation of three-dimensional renal structures. Methods (2008) 0.97
In-vitro reconstitution of three-dimensional human salivary gland tissue structures. Differentiation (2007) 0.97
High transduction efficiency of human amniotic fluid stem cells mediated by adenovirus vectors. Stem Cells Dev (2008) 0.97
Stem cell sources to treat diabetes. J Cell Biochem (2009) 0.97
Tissue engineering: current strategies and future directions. Chonnam Med J (2011) 0.96
Lack of major involvement of human uroplakin genes in vesicoureteral reflux: implications for disease heterogeneity. Kidney Int (2004) 0.96
Posterior urethral valves. ScientificWorldJournal (2009) 0.96
In vitro biocompatibility evaluation of naturally derived and synthetic biomaterials using normal human bladder smooth muscle cells. J Urol (2002) 0.96
Phenotypic and functional characterization of in vivo tissue engineered smooth muscle from normal and pathological bladders. J Urol (2002) 0.96
A liver-on-a-chip platform with bioprinted hepatic spheroids. Biofabrication (2016) 0.96
Co-electrospun dual scaffolding system with potential for muscle-tendon junction tissue engineering. Biomaterials (2010) 0.95
Reconstitution of human corpus cavernosum smooth muscle in vitro and in vivo. Tissue Eng (2002) 0.95
In vitro cardiomyogenic potential of human amniotic fluid stem cells. J Tissue Eng Regen Med (2011) 0.95
The use of thermal treatments to enhance the mechanical properties of electrospun poly(epsilon-caprolactone) scaffolds. Biomaterials (2007) 0.95
Human amniotic fluid stem cell injection therapy for urethral sphincter regeneration in an animal model. BMC Med (2012) 0.94
Porcine pancreas extracellular matrix as a platform for endocrine pancreas bioengineering. Biomaterials (2013) 0.94
Correction of diabetic erectile dysfunction with adipose derived stem cells modified with the vascular endothelial growth factor gene in a rodent diabetic model. PLoS One (2013) 0.94
Engineered cartilage covered ear implants for auricular cartilage reconstruction. Biomacromolecules (2010) 0.94
The use of keratin biomaterials derived from human hair for the promotion of rapid regeneration of peripheral nerves. Biomaterials (2007) 0.94
Autologous penile corpora cavernosa replacement using tissue engineering techniques. J Urol (2002) 0.94
Amniotic fluid stem cells improve survival and enhance repair of damaged intestine in necrotising enterocolitis via a COX-2 dependent mechanism. Gut (2013) 0.94
Peripheral nerve regeneration using acellular nerve grafts. J Biomed Mater Res A (2004) 0.94